Cerebras Systems, a pioneering AI chipmaking company, has hit another roadblock in its journey to go public. The company's initial public offering (IPO) has been delayed again, with the national security review of its listing still ongoing.

The delay is attributed to the incomplete staffing of the US Treasury Department, which oversees the Committee of Foreign Investment in the United States (CFIUS). The CFIUS is responsible for reviewing foreign investments in American companies, and Cerebras' IPO triggered a national security review due to a $335 million investment from Abu Dhabi-based G42, an AI holding company.

G42's ties to Chinese tech giant Huawei have raised concerns about potential national security risks. Huawei has been at the center of controversy in recent years, with the US government imposing strict sanctions on the company due to its alleged close ties with the Chinese government.

Cerebras originally filed its intent to IPO in September 2024, hoping that the incoming Trump administration would facilitate a smoother review process. However, the White House has yet to fill multiple vacancies, including the assistant Treasury secretary for investment security, which has slowed down the review process.

The delay is significant, as it not only affects Cerebras' plans to go public but also has broader implications for the AI chipmaking industry. The company's innovative technology has the potential to revolutionize the field of artificial intelligence, and a successful IPO could pave the way for further investments and advancements in the sector.

As the national security review continues, Cerebras remains tight-lipped about the delay. TechCrunch has reached out to the company for comment, and this story will be updated if a response is received.

The ongoing saga surrounding Cerebras' IPO serves as a reminder of the complex and often contentious landscape of technology investments. As the US government continues to scrutinize foreign investments in American companies, the delay highlights the need for clarity and transparency in the review process.

In the broader context, the delay also underscores the growing importance of artificial intelligence in the global technology landscape. As AI continues to transform industries and economies, the development of innovative chipmaking technology like Cerebras' will play a critical role in shaping the future of the sector.